Lactate Dehydrogenase-to-Lymphocyte Ratio Represents a Powerful Prognostic Tool of Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors.
Pathol Oncol Res
; 26(2): 1319-1324, 2020 Apr.
Article
in En
| MEDLINE
| ID: mdl-31388933
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Biomarkers, Tumor
/
Lymphocyte Count
/
Kidney Neoplasms
/
L-Lactate Dehydrogenase
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Pathol Oncol Res
Journal subject:
NEOPLASIAS
/
PATOLOGIA
Year:
2020
Type:
Article
Affiliation country:
China